CT visual quantitative evaluation of hypertensive patients with coronavirus disease (COVID-19): Potential influence of angiotensin converting enzyme inhibitors / angiotensin receptor blockers on severity of lung involvement

References

• Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine. 2020; Jan 29 38213: 1199–207. 10.1056/NEJMoa2001316
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507–13.doi:10.1016/S0140-6736(20)30211-7.
   PubMed Web of Science ®Google Scholar
• Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020. doi:10.1038/s41586-020-2008-3.
   Web of Science ®Google Scholar
• Rubin GD, Ryerson CJ, Haramati LB, Sverzellati N, Kanne JP, Raoof S, Schluger NW, Volpi A, Yim JJ, Martin IB, et al. The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner Society. Chest. 2020; 158(1), 106-116.
   Web of Science ®Google Scholar
• Choi H, Qi X, Yoon SH, Park SJ, Lee KH, Kim JY, Lee YK, Ko H, Kim KH, Park CM, et al. Extension of coronavirus disease 2019 (COVID-19) on chest CT and implications for chest radiograph interpretation. Radiology. Cardiothoracic Imaging. 2020;2(2):p.e200107.
   PubMedGoogle Scholar
• Joob B, Wiwanitkit V, Findings CCT. and Clinical Conditions of Coronavirus Disease (COVID-19). AJR Am J Roentgenol. 2020 Apr 1
   PubMed Web of Science ®Google Scholar
• Huang P, Liu T, Huang L, Liu H, Lei M, Xu W, Hu X, Chen J, Liu B.Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion. Radiology. 2020;295(1):22–23.
   PubMed Web of Science ®Google Scholar
• Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 2020 Feb 12.
   Web of Science ®Google Scholar
• Li K, Fang Y, Li W, Pan C, Qin P, Zhong Y, Liu X, Huang M, Liao Y, Li S. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol 2020 25 Mar;1. 30(8): 4407-4416.
   Web of Science ®Google Scholar
• Klimas J, Olvedy M, Ochodnicka‐Mackovicova K, Kruzliak P, Cacanyiova S, Kristek F, Krenek P, Ochodnicky P.Perinatally administered losartan augments renal ACE 2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats. J Cell Mol Med. 2015;19(8):1965–74.doi:10.1111/jcmm.12573.
   PubMed Web of Science ®Google Scholar
• Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher, PE.Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111(20):2605–10.
   PubMed Web of Science ®Google Scholar
• Li J, Wang X, Chen J, Zhang H, Deng. A. Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan. China JAMA Cardiology. 2020; Apr 23 57: 825. 10.1001/jamacardio.2020.1624
   PubMed Web of Science ®Google Scholar
• Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, Cui J, Xu W, Yang Y, Fayad ZA, et al. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology. 2020;295(1):202–07.doi:10.1148/radiol.2020200230.
   PubMed Web of Science ®Google Scholar
• General Office of National Health Committee. Notice on the issuance of a program for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (trial revised fifth edition). Accessed 3 Mar (2020)
   Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8.doi:10.1016/j.cell.2020.02.052.
   PubMed Web of Science ®Google Scholar
• Ferrario CMFJ, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE. Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2. Circulation. 2005;111(20):2605–10.
   PubMed Web of Science ®Google Scholar
• Karram T, Abbasi A, Keidar S, Golomb E, Hochberg I, Winaver J, Hoffman A, Abassi Z.Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure. Am J Physiol Heart Circ Physiol. 2005);;289(4):H1351–1358.doi:10.1152/ajpheart.01186.2004.
   PubMed Web of Science ®Google Scholar
• Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM.Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension. 2004;43(5):970–76.doi:10.1161/01.HYP.0000124667.34652.1a.
   PubMed Web of Science ®Google Scholar
• Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, Liu YM, Zhao YC, Huang X, Lin L, et al. Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19.
   Google Scholar
• American Heart Association (AHA), Heart Failure Society of America (HFSA) and American College of Cardiology (ACC). Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician. 2020. 21. International Society of Hypertension. A statement from the International Society of Hypertension on COVID-19. (2020)
   Google Scholar
• Bavishi C, Maddox TM, Messerli FH. Coronavirus disease. 2019. (COVID-19) infection and renin angiotensin system blockers. JAMA cardiology (2020)Apr 3. 5(7): 745-747.
   Google Scholar
• Igase M, Kohara K, Nagai T, Miki T, Ferrario CM. Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade. Hypertens Res. 2020;5(3):553–59. 10.1291/hypres.31.553CrossrefMedlineGoogle Scholar. doi:10.1291/hypres.31.553.
   Google Scholar
• Kuba K, Imai Y, Penninger JM. 2006; Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol. 6(3):271–76. doi:10.1016/j.coph.2006.03.001
   PubMed Web of Science ®Google Scholar
• Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112–16.doi:10.1038/nature03712.
   PubMed Web of Science ®Google Scholar
• Lei J, Li J, Li X, Qi X. CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. 2020 Apr;295(1):18–18. doi:10.1148/radiol.2020200236.
   PubMed Web of Science ®Google Scholar
• Fang Y, Zhang H, Xu Y, Xie J, Pang P, Ji W. CT Manifestations of Two Cases of 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. 2020;295(1):208–09. https://doi.org/10.1148/radiol. 2020200280. doi:10.1148/radiol.2020200280.
   PubMed Web of Science ®Google Scholar